Clinical Trial Update: Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating sequential BCMA-targeted CAR-T cell therapy after autologous stem cell transplantation in transplant-eligible newly diagnosed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA CAR-T cell therapy (investigational)

Snippet

Sponsor: Xuzhou Medical University | Conditions: Multiple Myeloma | Phase 1 | Status: NOT_YET_RECRUITING